tiprankstipranks
Trending News
More News >
Abbisko Cayman Limited (HK:2256)
:2256
Hong Kong Market

Abbisko Cayman Limited (2256) Similar Stocks

Compare
7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Abbisko Cayman Limited
HK$13.53
HK$9.20B
47.27
185.75%
5 Buy
0 Hold
0 Sell
Strong Buy
Alphamab Oncology
HK$10.67
HK$9.97B
40.68
203.99%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$12.63
HK$13.12B
-44.32
413.41%
0 Buy
1 Hold
0 Sell
Hold
HBM Holdings Ltd.
HK$12.51
HK$11.34B
16.93
869.77%
0 Buy
0 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$5.79
HK$8.17B
-18.58
126.17%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$8.71
HK$5.42B
140.94
0.11%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2256
Abbisko Cayman Limited
13.23
8.82
200.00%
HK:9966
Alphamab Oncology
10.67
7.16
203.99%
HK:1672
Ascletis Pharma, Inc.
12.63
10.17
413.41%
HK:2142
HBM Holdings Ltd.
12.51
11.22
869.77%
HK:2616
CStone Pharmaceuticals
5.79
3.45
147.44%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
8.71
0.01
0.11%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts